Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Effective treatments are available
50% of items were phrased as questions, with 28% in the first person
Reflected in the sales data, Eli Lilly's financial report shows that tirzepatide, with its two indications of blood - sugar control (Mounjaro) and weight loss (Zepbound), achieved a total revenue of $5 billion in Q1 2025, accounting for approximately 39% of the company's revenue during the same period, and its year - on - year growth rate exceeded 100%
Think of it as a single switch that both accelerates the engine and releases the brake at the same time
& Singh, G
US$ 29.33
US$ 23.75
US$ 22.76
